Stocks · Health care · Pharmaceutical Preparations

MANNKIND CORP

MNKD Clue Score45
United States Fiscal year ends December CIK 0000899460 Results filed 5 Nov 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Michael Castagna
17 Dec 2025
Chief Executive Officer
Sold after exercise
65,804
$6.01
$395.48K
Michael Castagna
16 Dec 2025
Chief Executive Officer
Sold after exercise
21,310
$6.00
$127.86K
Michael Castagna
12 Dec 2025
Chief Executive Officer
Sold after exercise
20,806
$6.00
$124.84K
David Thomson
2 Dec 2025
EVP Genl Counsel & Secretary
Sold after exercise
147,780
$5.57
$823.13K
Michael Castagna
2 Dec 2025
Chief Executive Officer
Sold after exercise
107,920
$5.57
$601.11K

What was left out

Form 4 filings counted 47
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 5
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 2,260,861
History held since 17 Oct 2006